DNAJC5 and malaria: The most advanced malaria vaccine candidate, MosquirixTM (RTS,S), was developed based on the conserved C-terminal domain and the central repeats domain of the P. falciparum CSP combined with the hepatitis B virus surface antigen (HBsAg).